For in vitro diagnostic use. Others Elecsys Anti-HBe IVD Elecsys® Anti-HBe CPS_000439 07026838190 Anti-HBe Elecsys E2G 300 Elecsys Anti-HBe 04015630940134 Reagents, kits 300 tests cobas e 402/801 true 11820613160 Anti-HBe Elecsys cobas e 100 Elecsys Anti-HBe 04015630938865 Reagents, kits 100 tests cobas e 602 true 11820613122 Anti-HBe Elecsys cobas e 100 Elecsys Anti-HBe 04015630911653 Reagents, kits 100 tests cobas e 411/601/602 true 07026838501 Elecsys Anti-HBe en 2 FF000000062B930E FF00000005206E0E 07026838190 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of total antibodies to hepatitis B e antigen (anti‑HBe) in human adult serum or plasma (potassium EDTA, lithium heparin, sodium citrate, sodium heparin) from individuals with symptoms of hepatitis or at risk for hepatitis B virus (HBV) infection. Assay results, in conjunction with other laboratory results and clinical information, may be used as an aid in the diagnosis of hepatitis B virus (HBV) infection in patients with symptoms of hepatitis or who may be at risk for HBV infection. A reactive test is presumptive laboratory evidence of HBV seroconversion. Further HBV serological marker testing is required to define the specific disease state.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e immunoassay analyzers. en 07026838500 Elecsys Anti-HBe en 4 FF00000004BBBA0E FF00000004638F0E 07026838190 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of human antibodies to the hepatitis B e antigen (HBeAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026838500 Elecsys Anti-HBe en 3 FF00000004638F0E FF00000000E8710E 07026838190 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of human antibodies to the hepatitis B e antigen (HBeAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07026838500 Elecsys Anti-HBe en 2 FF00000003E46B0E FF000000019DE20E 07026838190 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of human antibodies to the hepatitis B e antigen (HBeAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 801 immunoassay analyzer. en 11820613501 Elecsys Anti-HBe en 1 FF0000000497300E FF0000000497300E 11820613160 2325 cobas e 602 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative detection of total antibodies to hepatitis B e antigen (anti‑HBe) in human adult serum or plasma (potassium EDTA, lithium heparin, sodium citrate, sodium heparin) from individuals with symptoms of hepatitis or at risk for hepatitis B virus (HBV) infection. Assay results, in conjunction with other laboratory results and clinical information may be used as an aid in the diagnosis of hepatitis B virus (HBV) infection in patients with symptoms of hepatitis or who may be at risk for HBV infection. A reactive test is presumptive laboratory evidence of HBV seroconversion. Further HBV serological marker testing is required to define the specific disease state.The electrochemiluminescence immunoassay “ECLIA” is intended for use on the cobas e 602 immunoassay analyzer. en 11820613500 Elecsys Anti-HBe en 19 FF00000004BBA00E FF00000000315E0E 11820613122 618 cobas e 411 2325 cobas e 602 619 cobas e 601 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro qualitative determination of human antibodies to the hepatitis B e antigen (HBeAg) in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en